Lecture by Prof. Satoshi Uchida, Tokyo Medical and Dental University at the World Vaccine Congress 2024, USA Research on mRNA vaccines using DAICEL’s “Actranza® lab.”


On April 4, 2024, at the World Vaccine Congress 2024 (Washington, D.C., USA, April 1-4, 2024), Professor Satoshi Uchida of the Department of Advanced Nanomedical Engineering, Medical Research Institute, Tokyo Medical and Dental University (TMDU), gave a lecture on research results using “Actranza® lab.”, a novel administration device developed by DAICEL Corporation (President and CEO: Yoshimi Ogawa; Head Office: Osaka, Japan; hereinafter “DAICEL”) for use in animal testing.

Paper on this subject
Carrier-free mRNA vaccine induces robust immunity against SARS-CoV-2 in mice and non-human primates without systemic reactogenicity
Saed Abbasi, Miki Matsui-Masai, Fumihiko Yasui, Akimasa Hayashi, Theofilus A. Tockery, Yuki Mochida, Shiro Akinaga, Michinori Kohara, Kazunori Kataoka, Satoshi Uchida, Molecular Therapy, in press

Find out more


Links to related pages

News Top

Related Information